|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 应用中国商环包皮环切手术标准化方案对328例成年男性包皮环切的临床报告显示文摘目的:成年男性包皮环切手术标准化和培训可显著降低因手术引起的并发症发生率。由于目前国内外尚无可供参考的成年男性包皮环切手术标准化方案和培训制度,使得临床医生开展成年男性包皮环切手术的质量无法保证。为了建立成年男性包皮环切手术标准化和培训制度,便于临床医生和相关医护人员学习和掌握包皮环切器的临床应用技巧,以中国商环(简称'商环,ShangRing')包皮环切技术为例,根据商环的技术特点和临床实践经验,特别制订了商环包皮环切手术标准化方案,并将其标准化操作运用于临床。方法:采用商环包皮环切手术标准化方案对328例受术者(年龄18~58岁,平均27.8岁;已婚134例,未婚194例;包茎25例,包皮过长303例)进行包皮环切手术。对手术时间、疼痛评分(视觉模拟评分法,VAS)、术后并发症、包皮创口愈合时间、术后外观满意情况进行观察和随访。结果:手术时间为(4.70±1.31)min。手术时受术者疼痛(VAS)评分为(0.24±0.59)分,术后24h疼痛评分为(1.59±0.95)分,去环前24h内疼痛评分(1.72±1.11)分,去环时疼痛评分为(2.72±1.37)分。主要并发症发生率为术后感染0.6%(2/328)、出血0.6%(2/328)、伤口裂开0.6%(2/328)和水肿4.89%(16/328)。在发生出血和伤口裂开的受术者中无1例需要缝合。术后包皮创口完全愈合时间为(20.30±6.69)d。受术者对术后外观满意率99.7%(327/328)。结论:商环包皮环切术具有手术方式易于标准化、手术时间短、术中疼痛轻、术后无须特殊护理、容易完整保留系带,并完全暴露冠状沟、术后外观满意度高、受术者易于接受等优点。初步证明了中国商环包皮环切手术标准化方案的可接受性,严格按照此方案实施手术和随访护理,能最大化地实现商环包皮环切技术的诸多临床优势,将并发症发生率控制在可接受的范围内。 | 程跃 彭弋峰 刘毅东 田龙 吕年青 苏新军 严泽军 胡嘉盛 Richard LEE Howard KIM David C. SOKAL 李石华 | 2009 | 中华男科学杂志2009，15，7： | 155 |
| 2 | Hepatic fibrosis: It is time to go with hepatic stellate cell-specifictherapeutic targets显示文摘Hepatic fibrosis is a pathological lesion, characterized by the progressive accumulation of extracellular matrix(ECM) in the perisinusoidal space and it is a major problem in chronic liver diseases. Phenotypic activation of hepatic stellate cells(HSC) plays a central role in the progression of hepatic fibrosis. Retardation of proliferation and clearance of activated HSCs from the injured liver is an appropriate therapeutic strategy for the resolution and treatment of hepatic fibrosis. Clearance of activated HSCs from the injured liver by autophagy inhibitors, proapoptotic agents and senescence inducers with the high affinity toward the activated HSCs may be the novel therapeutic strategy for the treatment of hepatic fibrosis in the near future. | Devaraj Ezhilarasan Etienne Sokal Mustapha Najimi | 2018 | Hepatobiliary & Pancreatic Diseases International2018，17，3： | 56 |
| 3 | 中国商环(Shang Ring)男性包皮环切技术临床应用研究进展显示文摘男性包皮环切能显著降低男性阴茎-阴道性交获得性HIV感染风险大约60%,被WHO和联合国艾滋病规划署(UNAIDS)推荐作为HIV预防策略中的一个重要干预措施。寻求一种更加安全、有效和可接受的男性包皮环切器械和手术方法,以便能够满足加快执行扩大包皮环切预防HIV感染项目的需求,已经成为相关国际组织,特别是非洲国家政府公共卫生事业的当务之急。2008年中国商环(Shang Ring)包皮环切标准化手术方案的建立,以及应用这个标准化手术方案和手术培训在中国以及2009年和2010年在肯尼亚实施中国商环成人包皮环切手术获得有用的和有意义的临床数据,证明了中国商环包皮环切术的诸多优势。手术培训手册和教学视频的多次修订为培训医护人员提供了更加准确的教学指南。经过多家相关国际机构专家的考察和评估,中国商环包皮环切技术已经成为支持在非洲HIV高发地区扩大包皮环切服务预防HIV感染项目最具潜力的候选包皮环切器械之一。可以预计,中国商环包皮环切技术的成功应用将会在改变数百万非洲人的生活方式的同时,也为中国男科学与泌尿外科学医生在包皮环切与HIV预防和生殖健康相关的临床研究领域提供了丰富的机会。本文报告了2008年2月至2010年底期间中国商环包皮环切技术临床应用的国际和国内研究进展。 | 吕年青 李石华 David Sokal 程跃 彭弋峰 Mark Barone 黄翼然 Marc Goldstein | 2011 | 中华男科学杂志2011，17，3： | 44 |
| 4 | Stem cells for liver tissue repair:Current knowledge and perspectives显示文摘Stem cells from extra-or intrahepatic sources have been recently characterized and their usefulness for the generation of hepatocyte-like lineages has been demonstrated. Therefore, they are being increasingly considered for future applications in liver cell therapy. In that field, liver cell transplantation is currently regarded as a possible alternative to whole organ transplantation, while stem cells possess theoretical advantages on hepatocytes as they display higher in vitro culture performances and could be used in autologous transplant procedures. However, the current research on the hepatic fate of stem cells is still facing difficulties to demonstrate the acquisition of a full mature hepatocyte phenotype, both in vitro and in vivo. Furthermore, the lack of obvious demonstration of in vivo hepatocyte-like cell functionality remains associated to low repopulation rates obtained after current transplantation procedures. The present review focuses on the current knowledge of the stem cell potential for liver therapy. We discuss the characteristics of the principal cell candidates and the methods to demonstrate their hepatic potential in vitro and in vivo. We finally address the question of the future clinical applications of stem cells for liver tissue repair and the technical aspects that remain to be investigated. | Philippe A Lysy David Campard Fran oise Smets Mustapha Najimi Etienne M Sokal | 2008 | World Journal of Gastroenterology2008，14，6： | 22 |
| 5 | Use of mesenchymal stem cells to treat liver fibrosis:Current situation and future prospects显示文摘Progressive liver fibrosis is a major health issue for which no effective treatment is available,leading to cirrhosis and orthotopic liver transplantation.However,organ shortage is a reality.Hence,there is an urgent need to find alternative therapeutic strategies.Cellbased therapy using mesenchymal stem cells(MSCs) may represent an attractive therapeutic option,based ontheir immunomodulatory properties,their potential to differentiate into hepatocytes,allowing the replacement of damaged hepatocytes,their potential to promote residual hepatocytes regeneration and their capacity to inhibit hepatic stellate cell activation or induce their apoptosis,particularly via paracrine mechanisms.The current review will highlight recent findings regarding the input of MSC-based therapy for the treatment of liver fibrosis,from in vitro studies to pre-clinical and clinical trials.Several studies have shown the ability of MSCs to reduce liver fibrosis and improve liver function.However,despite these promising results,some limitations need to be considered.Future prospects will also be discussed in this review. | Silvia Berardis Prenali Dwisthi Sattwika Mustapha Najimi Etienne Marc Sokal | 2015 | World Journal of Gastroenterology2015，21，3： | 22 |
| 6 | Liver cell transplantation for Crigler-Najjar syndrome type Ⅰ: Update and perspectives显示文摘Liver cell transplantation is an attractive technique to treat liver-based inborn errors of metabolism. The feasibility and efficacy of the procedure has been demonstrated, leading to medium term partial metabolic control of various diseases. Crigler-Najjar is the paradigm of such diseases in that the host liver is lacking one function with an otherwise normal parenchyma. The patient is at permanent risk for irreversible brain damage. The goal of liver cell transplantation is to reduce serum bilirubin levels within safe limits and to alleviate phototherapy requirements to improve quality of life. Preliminary data on Gunn rats, the rodent model of the disease, were encouraging and have led to successful clinical trials. Herein we report on two additional patients and describe the current limits of the technique in terms of durability of the response as compared to alternative therapeutic procedures. We discuss the future developments of the technique and new emerging perspectives. | Philippe A Lysy Mustapha Najimi Xavier Stéphenne Annick Bourgois Franoise Smets Etienne M Sokal | 2008 | World Journal of Gastroenterology2008，14，22： | 9 |
| 7 | Hepatocyte cryopreservation:Is it time to change the strategy?显示文摘Liver cell transplantation presents clinical benefit in patients with inborn errors of metabolism as an alternative,or at least as a bridge,to orthotopic liver transplantation.The success of such a therapeutic approach remains limited by the quality of the transplanted cells.Cryopreservation remains the best option for long-term storage of hepatocytes,providing a permanent and sufficient cell supply.However, isolated adult hepatocytes are poorly resistant to such a process,with a significant alteration both at the morphological and functional levels.Hence,the aim of the current review is to discuss the state of the art regarding widely-used hepatocyte cryopreservation protocols,as well as the assays performed to analyse the post-thawing cell quality both in vitro and in vivo. The majority of studies agree upon the poor quality and efficiency of cryopreserved/thawed hepatocytes as compared to freshly isolated hepatocytes.Intracellular ice formation or exposure to hyperosmotic solutionsremains the main phenomenon of cryopreservation process,and its effects on cell quality and cell death induction will be discussed.The increased knowledge and understanding of the cryopreservation process will lead to research strategies to improve the viability and the quality of the cell suspensions after thawing.Such strategies,such as vitrification,will be discussed with respect to their potential to significantly improve the quality of cell suspensions dedicated to liver cell-based therapies. | Xavier Stéphenne Mustapha Najimi Etienne M Sokal | 2010 | World Journal of Gastroenterology2010，16，1： | 9 |
| 8 | Silibinin induces hepatic stellate cell cycle arrest via enhancing p53/p27 and inhibiting Akt downstream signaling protein expression显示文摘BACKGROUND: Proliferation of hepatic stellate cells(HSCs) plays a pivotal role in the progression of liver fibrosis consequent to chronic liver injury. Silibinin, a flavonoid compound,has been shown to possess anti-fibrogenic effects in animal models of liver fibrosis. This was attributed to an inhibition of cell proliferation of activated HSCs. The present study was to gain insight into the molecular pathways involved in silibinin anti-fibrogenic effect. METHODS: The study was conducted on LX-2 human stellate cells treated with three concentrations of silibinin(10, 50 and 100 μmol/L) for 24 and 96 hours. At the end of the treatment cell viability and proliferation were evaluated. Protein expression of p27, p21, p53, Akt and phosphorylated-Akt was evaluated by Western blotting analysis and Ki-67 protein expression was by immunocytochemistry. Sirtuin activity was evaluated by chemiluminescence based assay. RESULTS: Silibinin inhibits LX-2 cell proliferation in doseand time-dependent manner; we showed that silibinin upregulated the protein expressions of p27 and p53. Such regulation was correlated to an inhibition of both downstream Akt and phosphorylated-Akt protein signaling and Ki-67 protein expression. Sirtuin activity also was correlated to silibinininhibited proliferation of LX-2 cells. CONCLUSION: The anti-proliferative effect of silibinin on LX-2 human stellate cells is via the inhibition of the expressions of various cell cycle targets including p27, Akt and sirtuin signaling. | Devaraj Ezhilarasan Jonathan Evraerts Brice Sid Pedro Buc Calderon Sivanesan Karthikeyan Etienne Sokal Mustapha Najimi | 2017 | Hepatobiliary & Pancreatic Diseases International2017，16，1： | 7 |
| 9 | 运动皮层刺激疗法(MCS)缓解慢性中枢神经病理性疼痛显示文摘运动皮层刺激疗法(MCS)是一种神经调控方法,可用于治疗难治性中枢神经病理性疼痛。本文目的在于评价MCS的治疗效果。方法:(1)研究对象:14名中枢神经病理性疼痛患者(9男5女),分别患有丘脑痛、非典型面部疼痛、臂丛神经撕脱伤痛、幻肢痛和脊髓空洞症等疾病。患者的年龄范围从42岁到64岁,平均年龄58岁。 | Sokal P 孙名帅 | 2016 | 中国疼痛医学杂志2016，22，2： | 3 |
| 10 | Chronic hepatitis B in children and adolescents显示文摘 | Massimiliano Paganelli Xavier Stephenne Etienne M. Sokal | 2012 | Journal of Hepatology2012，，4： | 3 |
| 11 | Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines显示文摘 | Etienne M. Sokal Massimiliano Paganelli Stefan Wirth Piotr Socha Pietro Vajro Florence Lacaille Deirdre Kelly Giorgina Mieli-Vergani | 2013 | Journal of Hepatology2013，，： | 3 |
| 12 | Epithelial cells with hepatobiliary phenotype:Is it another stem cell candidate for healthy adult human liver?显示文摘AIM:To investigate the presence and role of liver epithelial cells in the healthy human adult liver.METHODS:Fifteen days after human hepatocyte primary culture,epithelial like cells emerged and started proliferating.Cell colonies were isolated and sub-cultured for more than 160 d under specific culture conditions.Cells were analyzed for each passage using immunofluorescence,flow cytometry and reverse transcription-polymerase chain reaction(RT-PCR).RESULTS:Flow cytometry analysis demonstrated that liver epithelial cells expressed common markers for hepatic and stem cells such as CD90,CD44 and CD29 but were negative for CD34 and CD117.Using immunofluorescence we demonstrated that liver epithelial cells expressed not only immature(α-fetoprotein)but also differentiated hepatocyte(albumin and CK-18)and biliary markers(CK-7 and 19),whereas they were negative for OV-6.RT-PCR analysis confirmed immunofluorescence data and revealed that liver epithelial cells did not express mature hepatocyte markers such as CYP2B6,CYP3A4 and tyrosine amino-transferase.Purified liver epithelial cells were transplanted into SCID mice.One month after transplantation,albumin positive cell foci were detected in the recipient mouse parenchyma.CONCLUSION:According to their immature and bipotential phenotype,liver epithelial cells might represent a pool of precursors in the healthy human adult liver other than oval cells. | Dung Ngoc Khuu Mustapha Najimi Etienne M Sokal | 2007 | World Journal of Gastroenterology2007，13，10： | 3 |
| 13 | The wide spectrum of multidrug resistance 3 deficiency: From neonatal cholestasis to cirrhosis of adulthood显示文摘 | Emmanuel Jacquemin J. Marleen L. De Vree Danièle Cresteil Etienne M. Sokal Ekkehard Sturm Micheline Dumont George L. Scheffer Marianne Paul Martin Burdelski Piter J. Bosma Olivier Bernard Michelle Hadchouel Ronald P.J. Oude Elferink | 2001 | Gastroenterology2001，，6： | 2 |
| 14 | Staging and progrnosis in chronic myelogenous leukem ia显示文摘 | SOKAL J E BACCARANIM TURA S | 1988 | Sere in Hematol1988，25，： | 1 |
| 15 | Preferential inhibition by cytarabine of CFU-GM from patients with chronic granulocytic leukemia 显示文摘 | Sokal JE Leong SS Goemz GA | 1987 | Cancer1987，59，3： | 1 |
| 16 | A dose ranging study of the pharmacokineties,safety,and preliminary efficacy of lamivudine in children and adolescents with chronic hepatitis B 显示文摘 | Sokal EM Roberts EA Mieli-Vergani G | 2000 | Antimicrob Agents Chemiother2000，44，2： | 1 |
| 17 | Spatial autocorrelation in biology显示文摘 | Sokal R R Oden N L | 1978 | Methodology Biol J Linn Soc1978，10，： | 1 |
| 18 | Spatial autocorrelation in biology: 1 Mtehodology显示文摘 | Sokal R R Oden N L | 1978 | Biological Journal of Linnean Society1978，10，2： | 1 |
| 19 | Reeombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young aduhs显示文摘 | Sokal E M Hoppenbrouwers K Vandermeulen C | 2007 | Journal of Infectious Diseases2007，196，12： | 1 |
| 20 | The I- talian Cooperative CML Study Group: prognostic discrimination in good risk chronic granulocytic leukemia 显示文摘 | SOKAL J E COX E B BACCARANIM | 1984 | Blood1984，63，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员